Pembrolizumab vs Valsartan
Pembrolizumab vs Valsartan: Overview
This comparison examines the pharmacological differences between Pembrolizumab and Valsartan.
Mechanism of Action
Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.
Valsartan: Angiotensin II type 1 receptor blocker.
Pharmacokinetics
Half-life: Pembrolizumab — 26 days; Valsartan — 6 hours.
Chemical Properties
Molecular Formula: Valsartan — C24H29N5O3.
Molecular Weight: Valsartan — 435.5190 g/mol.
Type: Pembrolizumab — Antibody; Valsartan — Small molecule.